View Rule
View EO 12866 Meetings | Printer-Friendly Version Download RIN Data in XML |
SSA | RIN: 0960-AF88 | Publication ID: Fall 2011 |
Title: Revised Medical Criteria for Evaluating Hematological Disorders (974P) | |
Abstract: Sections 7.00 and 107.00, Hematological Disorders, of appendix 1 to subpart P of part 404 of our regulations, describe hematological disorders that we consider severe enough to prevent a person from performing any gainful activity or that cause marked and severe functional limitation for a child claiming Supplemental Security Income payments under title XVI. We are proposing to revise the criteria in these sections to ensure that the medical evaluation criteria are up to date and consistent with the latest advances in medical knowledge and treatment. | |
Agency: Social Security Administration(SSA) | Priority: Other Significant |
RIN Status: Previously published in the Unified Agenda | Agenda Stage of Rulemaking: Proposed Rule Stage |
Major: No | Unfunded Mandates: No |
CFR Citation: 20 CFR 404.1500, app 1 | |
Legal Authority: 42 USC 402 42 USC 405(a) 42 USC 405(b) 42 USC 405(d) to 405(h) 42 USC 416(i) 42 USC 421(a) 42 USC 421(i) 42 USC 423 42 USC 902(a)5) 42 USC 1381a 42 USC 1382c 42 USC 1383 42 USC 1383b |
Legal Deadline:
None |
||||||
Statement of Need: These proposed regulations are necessary to update the hematological listings to reflect advances in medical knowledge, treatment, and methods of evaluating hematological disorders. The changes ensure that determinations of disability have a sound medical basis, that claimants receive equal treatment through the use of specific criteria, and that people who are disabled can be readily identified and awarded benefits if all other factors of entitlement or eligibility are met. |
||||||
Summary of the Legal Basis: Administrative--not required by statute or court order. |
||||||
Alternatives: We considered not revising the listings or making only minor technical changes and continuing to use our current criteria. However, we believe that proposing these revisions is preferable because of the medical advances that have been made in treating and evaluating these types of impairments. |
||||||
Anticipated Costs and Benefits: Estimated savings--low. |
||||||
Risks: None. |
||||||
Timetable:
|
Additional Information: Includes Retrospective Review under E.O. 13563. | |
Regulatory Flexibility Analysis Required: No | Government Levels Affected: None |
Small Entities Affected: No | Federalism: No |
Included in the Regulatory Plan: Yes | |
Public Comment URL: www.regulations.gov | |
RIN Data Printed in the FR: No | |
Agency Contact: Cheryl A. Williams Director Social Security Administration Office of Medical Policy, 6401 Security Boulevard, Baltimore, MD 21235-6401 Phone:410 965-1020 Email: cheryl.a.williams@ssa.gov Brian Rudick Social Insurance Specialist, Regulations Writer Social Security Administration Office of Regulations and Reports Clearance, 6401 Security Boulevard, Baltimore, MD 21235-6401 Phone:410 965-1483 Email: brian.rudick@ssa.gov |